Analyst Research

Report Title Price
Thomson Reuters Stock Report - SIHUAN PHARMACEUTICAL CO., LTD. (000605-SZ)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Sihuan Pharmaceutical Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Wright Investors Service Comprehensive Report for Sihuan Pharmaceutical Co., Ltd.
Provider: Wright Reports
$472.00
Buy
Sihuan Pharmaceutical Co.,Ltd. (000605) - Financial Analysis Review
Provider: GlobalData
$125.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Sihuan Pharmaceutical Co Ltd Announces FY 2012 Net Profit Outlook


Thursday, 17 Jan 2013 07:00pm EST 

Sihuan Pharmaceutical Co Ltd announced that it expects its net profit for fiscal year (FY) 2012 to be approximately RMB 5 million to RMB 6 million, compared to that of FY 2011 (RMB -1.8336 million). The Company cited the increased sales income as the main reason for this forecast. 

Latest Developments for Sihuan Pharmaceutical Co Ltd

Latest Key Developments in Pharmaceuticals

Company Quote

Sihuan Pharmaceutical Co Ltd
(000605.SZ)
15.79
-0.2 -1.25%
10:10pm EDT